glp-1 compounding news november 2025 FDA Crackdown on Compounded Drugs FDA issued 25 warning letters

Your clinician must document a genuine diagnosis

Todays Sources: Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists Comparison of the efficacy and safety of 10 glucagon-like peptide-1 GLP-1 diabetes and weight-loss drug side effects - Harvard Health Ozempic Could Crush the Junk Food Industry

Instead of reacting to trend reports, they are building continuous insight engines that track what happens when consumers stay on GLP-1s for 3 months, 6 months, 12 months, and what happens when they stop

Bakris GL, Agarwal R, Chan JC et al (2015) Effect of finerenone on albuminuria in patients with diabetic nephropathy a randomized clinical trial